Memorial Sloan Kettering Cancer Center-ko ikertzaileekin lankidetzan egindako argitalpenak (15)

2024

  1. Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma

    Blood cancer discovery, Vol. 5, Núm. 3, pp. 146-152

2021

  1. Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms

    Leukemia, Vol. 35, Núm. 12, pp. 3542-3550

2020

  1. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 1

2018

  1. Extracellular vesicles in DLBCL provide abundant clues to aberrant transcriptional programming and genomic alterations

    Blood, Vol. 132, Núm. 7, pp. e13-e23

2017

  1. BCL6 antagonizes NOTCH2 to maintain survival of human follicular lymphoma cells

    Cancer Discovery, Vol. 7, Núm. 5, pp. 506-521

  2. Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

    The Lancet, Vol. 390, Núm. 10094, pp. 555-566

  3. CREBBP inactivation promotes the development of HDAC3-dependent lymphomas

    Cancer Discovery, Vol. 7, Núm. 1, pp. 38-53

2015

  1. The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development

    Nature Medicine, Vol. 21, Núm. 10, pp. 1199-1208

2014

  1. Point mutation E1099K in MMSET/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies

    Leukemia

2013

  1. EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation

    Cancer Cell, Vol. 23, Núm. 5, pp. 677-692

2003

  1. De novo erythroleukemia chromosome features include multiple rearrangements, with special involvement of chromosomes 11 and 19

    Genes Chromosomes and Cancer, Vol. 36, Núm. 4, pp. 406-412

2001

  1. Comparative genomic hybridization and amplotyping by arbitrarily primed PCR in stage A B-CLL

    Cancer Genetics and Cytogenetics, Vol. 130, Núm. 1, pp. 8-13

  2. Frequent gain of chromosome 19 in megakaryoblastic leukemias detected by comparative genomic hybridization

    Genes Chromosomes and Cancer, Vol. 32, Núm. 3, pp. 285-293

1998

  1. Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization

    Blood, Vol. 91, Núm. 8, pp. 3007-3010

  2. Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma

    Blood, Vol. 92, Núm. 5, pp. 1743-1748